Search results
403 results found
Antisense oligonucleotides: new therapies for n = 1 rare diseasesBlogSome of diseases are so rare that only a single case (n = 1) or a few cases (n = few) are known globally. Therefore, rare disease patients need highly individualised treatments. Antisense oligonucleotides promise hope
Viral genetic surveillance, the canary in the coal mine for emerging diseases – a look at avian fluBlogWith the current pandemic of bird flu there is a growing concern around diseases spilling over from animals to humans.
Electrogenetic systems for type 1 diabetesBlogThere is a new field of research in synthetic biology called ‘electrogenetics’ that is exploring the use of tiny medical devices containing specially designed insulin-producing cells to help patients manage type 1 diabetes.
Informing the NHS 10 year planBlogWe are planning to convene an online event on 22 November to inform a contribution to the NHS ten year plan consultation. Find out more here.
The Sudlow Review – can it succeed where others have failed?BlogRead our summary of the recently published - and in our view, excellent - report, which we hope will galvanise policy makers, healthcare professionals and funders to collaborate on better use of existing data
Gene therapies and AI – is this the next phase of genomic medicine?BlogHeather Turner, reports from the recent British Society of Genomic Medicine Annual Conference which set tone for the next phase of genomics medicine.
Phages: A virus on our side? Insights from our podcastBlogOfori Canacoo provides a peek behind the scenes, as well as his takeways from each episode. Here are his thoughts from the phages episode.